Literature DB >> 15209737

Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma.

T Noguchi1, S Wada, S Takeno, T Hashimoto, H Moriyama, Y Uchida.   

Abstract

Aggressive surgery including extensive lymph node dissection is considered necessary to improve the long-term survival of patients with esophageal carcinoma. While three-field lymph node dissection is widely performed for patients with thoracic esophageal carcinoma, cervical lymph node metastasis is uncommon. In order to reduce surgical stress, we have developed a two-step three-field lymph node dissection procedure for thoracic esophageal carcinoma. In the first-step operation, total thoracic esophagectomy through a right thoracotomy is performed. Mediastinal and abdominal lymph node dissection is performed synchronously. When recurrent nerve lymph node metastasis is pathologically positive, cervical lymph node dissection is performed about 3 weeks after the first operation (second step). Of 343 patients with carcinoma of the esophagus surgically treated in our department between 1990 and 2001, 146 underwent the operation described above. Three-field dissection was performed in 68 patients (group A), while two-field dissection was performed in 78 patients (group B). In the 68 group A patients, cervical lymph node metastasis was positive in 15 patients (22%). There was no marked difference in the onset of major complications between the two groups. The 5-year survival rate was 58% for group A and 61% for group B, not a statistically significant difference. In 78 of the 146 patients, it was possible to avoid cervical lymph node dissection without negatively affecting therapeutic outcomes. Two-step three-field lymph node dissection can reduce surgical stress of patients with good clinical outcome. Copyright 2004 ISDE

Entities:  

Mesh:

Year:  2004        PMID: 15209737     DOI: 10.1111/j.1442-2050.2004.00353.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.

Authors:  Yi Ren; Chang Su; Yang Zhou; Xiang Zhao; Cheng-Liang Yang; Yong-Yu Liu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

2.  Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy.

Authors:  Yang Yu; Zhou Wang; Zhe Yang; Xiang-Yan Liu
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

Review 3.  Three-field lymph node dissection in treating the esophageal cancer.

Authors:  Qi-Xin Shang; Long-Qi Chen; Wei-Peng Hu; Han-Yu Deng; Yong Yuan; Jie Cai
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 4.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.

Authors:  Guo-Wei Ma; Dong-Rong Situ; Qi-Long Ma; Hao Long; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 5.  Esophageal Cancer: Current Options for Therapeutic Management.

Authors:  Li Sun; Hongwei Zhang; Kaichun Wu
Journal:  Gastrointest Tumors       Date:  2014-05-09

6.  Supraclavicular lymph node metastasis in elderly patients undergoing esophageal squamous cell carcinoma radical surgery: construction of risk and prognostic predictive nomograms.

Authors:  Ling Chen; Shaobin Yu; Xiaohong Jiang; Mingqiang Kang
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

Review 7.  Esophageal cancer with a double aortic arch: a case report and literature review.

Authors:  Kai Kang; Sheng Wang; Fei Xiong; Jindan Kai; Jianjian Wang; Binfeng Li
Journal:  J Cardiothorac Surg       Date:  2022-03-11       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.